/WLLW.TO
WLLW.TO Stock - Willow Biosciences Inc.
Healthcare|Drug Manufacturers - Specialty & GenericTSX
$0.04+16.67%
+$0.01 (+16.67%) • Jun 20
35
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.SELL
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.04
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for WLLW.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.03 – $0.04
TARGET (TP)$0.04
STOP LOSS$0.03
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta4.65
52W High$0.72
52W Low$0.03
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.66M | $1.17M | $821,000 | $133,000 | $10,000 |
| Gross Profit | $3.28M | $-659,000 | $-6,652,000 | $-11,400,000 | $10,000 |
| Gross Margin | 70.3% | -56.2% | -810.2% | -8571.4% | 100.0% |
| Operating Income | $-5,991,000 | $-13,182,000 | $-18,393,000 | $-23,330,000 | $-23,061,000 |
| Net Income | $-6,189,000 | $-13,029,000 | $-14,814,000 | $-6,167,000 | $-33,986,000 |
| Net Margin | -132.8% | -1111.7% | -1804.4% | -4636.8% | -339860.0% |
| EPS | $-0.05 | $-0.10 | $-0.12 | $-0.05 | $-0.41 |
Company Overview
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
WLLW.TOBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q4 2025 | Nov 10, 2025 | — | — | — | — |
Q3 2025 | Aug 11, 2025 | — | — | — | — |
Q2 2025 | May 12, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 25, 2025 | — | $-0.01 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 12, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 13, 2024 | — | $-0.02 | — | — |
Q1 2024 | Mar 28, 2024 | — | $-0.02 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.02 | — | — |
Q3 2023 | Aug 8, 2023 | — | $-0.03 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.04 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.04 | — | — |
Q4 2022 | Nov 3, 2022 | — | $-0.03 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.05 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.03 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.05 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.10 | — | — |
Latest News
Loading news...
Frequently Asked Questions about WLLW.TO
What is WLLW.TO's current stock price?
Willow Biosciences Inc. (WLLW.TO) is currently trading at $0.04 per share. The stock has moved +16.67% today.
What is the analyst price target for WLLW.TO?
No analyst price targets are currently available for this stock.
What sector is Willow Biosciences Inc. in?
Willow Biosciences Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the TSX exchange.
What is WLLW.TO's market cap?
Willow Biosciences Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does WLLW.TO pay dividends?
No, Willow Biosciences Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBAMM.CN
Body and Mind Inc.
$0.03
Mkt Cap: $0.0B
BCBC.CN
The BC Bud Corporation
$0.04
Mkt Cap: $0.0B
BHNG.CN
Bhang Inc.
$0.02
Mkt Cap: $0.0B
CANN.CN
Heritage Cannabis Holdings Corp.
$0.01
Mkt Cap: $0.0B
CMND.CN
Clearmind Medicine Inc.
$1.60
Mkt Cap: $0.0B
FFNT.CN
4Front Ventures Corp.
$0.01
Mkt Cap: $0.0B
FH.NE
Filament Health Corp.
$0.01
Mkt Cap: $0.0B
LUFF.CN
Luff Enterprises Ltd.
$0.01
Mkt Cap: $0.0B
SNN.CN
Sunniva Inc.
$0.15
Mkt Cap: $0.0B
SZLS.TO
StageZero Life Sciences Ltd.
$0.04
Mkt Cap: $0.0B
Explore stocks similar to WLLW.TO for comparison